BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Authors
» Jennifer Boggs
Jennifer Boggs
Articles
ARTICLES
Changes to delay EPIX trial of blood clot imaging agent
July 28, 2005
By
Jennifer Boggs
Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming
July 28, 2005
By
Jennifer Boggs
Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming
July 28, 2005
By
Jennifer Boggs
Valeant Prepares For Phase III Retigabine Studies In Epilepsy
July 27, 2005
By
Jennifer Boggs
Valeant Prepares For Phase III Retigabine Studies In Epilepsy
July 27, 2005
By
Jennifer Boggs
Novacea Gains Rights To Oral Vinorelbine From Pierre Fabre
July 26, 2005
By
Jennifer Boggs
Novacea Gains Rights To Oral Vinorelbine From Pierre Fabre
July 26, 2005
By
Jennifer Boggs
Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial
July 25, 2005
By
Jennifer Boggs
Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial
July 25, 2005
By
Jennifer Boggs
Dendreon Rises On Provenge Survival Data; Considers BLA
July 22, 2005
By
Jennifer Boggs
View All Articles by Jennifer Boggs
